Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. - Wikidata - awgldk - TriplyDB

Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.

Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.

http://www.wikidata.org/entity/Q35609692

about

Gallbladder Cancer in the 21st Century.Nomograms in oncology: more than meets the eye Adjuvant Therapy for Gallbladder Cancer: an Analysis of the National Cancer Data Base.Adjuvant Therapy for Resected Gallbladder Cancer: Analysis of the National Cancer Data Base.Adjuvant therapy in biliary tract and gall bladder carcinomas: a review.Analysis of prognostic factors for survival after surgery for gallbladder cancer based on a Bayesian network.Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes among Patients with Resected Gallbladder Cancer: A Multi-institutional Analysis.Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma.Chemotherapy and targeted therapy for gall bladder cancer.Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III A nomogram for predicting the likelihood of lymph node metastasis in early gastric patients.Gallbladder cancer: expert consensus statement.SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.Therapeutic Potential of Adjuvant Stereotactic Body Radiotherapy for Gallbladder Cancer Nuclear expression of thioredoxin-1 in the invasion front is associated with outcome in patients with gallbladder carcinoma Biliary tract cancers: SEOM clinical guidelines Methods in comparative effectiveness research.Nomogram for predicting lymph node metastasis rate of submucosal gastric cancer by analyzing clinicopathological characteristics associated with lymph node metastasis.Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram.Gallbladder Carcinoma, the Difficulty of Early Detection: A Case Report.Bile duct involvement portends poor prognosis in resected gallbladder carcinoma Is There a Role for Adjuvant Therapy in R0 Resected Gallbladder Cancer?: A Propensity Score-Matched Analysis.Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies.Outcomes in biliary malignancy.New Horizons for Precision Medicine in Biliary Tract Cancers.Limited Use of Adjuvant Therapy in Patients With Resected Gallbladder Cancer Despite a Strong Association With Survival.Future Therapy of Cholangiocarcinoma.Gallbladder cancer: results achieved and future challenges.Decision of surgical approach for advanced gallbladder adenocarcinoma based on a Bayesian network.Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience.Conditional survival in patients with gallbladder cancer.The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.Prediction of esophageal stricture in patients given locoregional triamcinolone injections immediately after endoscopic submucosal dissection.Evaluation of dynamic contrast-enhanced MRI derived microvascular permeability in recurrent glioblastoma treated with bevacizumab.Nomogram predicting pulmonary metastasis of hepatocellular carcinoma after liver transplantation.Adjuvant Chemoradiotherapy is Associated with Improved Survival for Patients with Resected Gallbladder Carcinoma: A Systematic Review and Meta-analysis.A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma.Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer.A nomogram to predict overall survival for biliary tract cancer.

P2860

Q26784174-156432B0-F2C5-49D9-A7A7-93D81E3C8EE6 Q26830260-25129964-FD78-4454-B88B-894DAC71CC4D Q30988473-16B949CE-51BE-48FF-AF2F-5B417BE2AAC4 Q31135072-0D8C6517-8BA9-4AC7-A4E0-5234090D6FDD Q33593250-1D1CAA42-BC6A-46C9-BEAF-6D1D32C96CD1 Q33672198-9CBB967E-8A2F-4814-9F7C-8A508BF87F24 Q33757744-45572CAE-3024-4F52-81E7-C5623F6A0500 Q33844564-CE11DEF8-2931-4B6E-826E-7EC085BE76C7 Q33977171-7B0D5556-D8A8-476B-A435-3655BECEA804 Q35728465-05981A28-8BE9-4013-94B4-900CC1A147E5 Q35923072-9399488D-3681-4F0B-9E0F-E187B4CE7881 Q35924976-450E765F-2FA5-457A-9F2A-B6C69288CD2A Q35947011-E5774CFC-9765-476D-91B5-91C1A4CC8F54 Q36067376-757F2F19-EDE8-4372-AEFC-D27EFD84662A Q36288778-4972AA73-E0A4-41FB-BC1C-6BD7FAA855E4 Q36400234-5C065417-3EE6-46C1-A224-5ED5E7698E5C Q36417734-48B42E55-B3D6-41D0-9C95-F9D7D431F7AC Q36419133-86FD0B52-172B-4C13-91B9-B05641BD593A Q36583009-6631EDE1-A2A3-4F1E-99B9-F1CC6B245565 Q36689250-F94FD033-A01C-4935-BE50-B14299B4883E Q37197016-1291EEBF-7893-4751-A8AA-D0C34F44C3D6 Q37367398-B9B808F0-3F37-4271-A11B-430E49F54EA8 Q37983692-6C94B849-420B-45E0-B472-51FBF058BC6C Q38253816-84FBBC44-8AC6-4BB3-AD00-084FBF022E38 Q38619219-B5B11350-0A2E-4AAF-B1C3-CDA18277CC79 Q38735122-B6FCDFA4-2997-4ACD-9D7B-B69F00479B6E Q38754382-FF090DC9-2E78-4D25-8EFC-14D5FF819491 Q38797010-84CAB054-7324-4E0A-9756-7B7779124B1A Q40055998-F6A11706-1360-4C9A-8447-0CAB79FEBE5F Q46575353-6023680F-A3C6-4535-B7AE-A19490A886E2 Q47101832-CB8143EF-3E55-4B0E-B58C-35E53FC80D87 Q47788256-C0EC5BB9-CD0C-4854-8152-8BE6F0F9B738 Q47919592-9E367D3D-0EB4-42B9-AABC-A6A84BE486B8 Q48248412-F28F5A68-2F03-4EC9-B1CF-DD4A6E04137A Q48469860-277CB6FA-E9F3-48D1-ABFB-14133F557220 Q48507271-7CDDA64A-4F00-4576-A061-9308977408FA Q50100553-EAE91058-AB7F-458C-8ECD-A7CB314E40ED Q52629233-4C2D6AD1-5C99-44AD-B141-615019E89C92 Q54369031-AFF16D79-5C7E-473A-A1CD-ABA3CA48B1D0 Q55282964-AA75B11E-F0D9-44AB-9AA3-2D3F2FD6C798

P2860

Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.

http://www.wikidata.org/entity/Q35609692

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Nomogram for predicting the be ...... r resected gallbladder cancer.

@ast

Nomogram for predicting the be ...... r resected gallbladder cancer.

@en

type

label

Nomogram for predicting the be ...... r resected gallbladder cancer.

@ast

Nomogram for predicting the be ...... r resected gallbladder cancer.

@en

prefLabel

Nomogram for predicting the be ...... r resected gallbladder cancer.

@ast

Nomogram for predicting the be ...... r resected gallbladder cancer.

@en

P1433

Q35609692-41616B94-2302-4FD8-8039-CCE571048EEA

P1476

Q35609692-A81A7D78-BB14-485D-8BE2-5BE8865422CE

P2093

Q35609692-2679786E-5C4A-4E08-92C9-4558AA520BEC

Q35609692-4E28140B-5023-4BB0-A54F-396B7B8C2CBB

Q35609692-6AB9D263-D333-4D64-AC81-BE20911F8E8A

Q35609692-E9FDF4E4-B282-4D39-B4B4-E4D2FFC8F195

Q35609692-EF5A718F-5CF9-4B70-8E24-C16623B7F239

Q35609692-F52E7E62-B28D-41A6-93C9-1BEBF046B75B

P2860

Q35609692-0B855F51-0C31-4145-B419-85B62F919DD6

Q35609692-14B085B0-CBD6-4985-ADB0-DB241034E535

Q35609692-166C4049-BE6C-4352-84B4-A51921F824D3

Q35609692-177A6187-F57A-4068-A032-B83383A33D83

Q35609692-1FF81599-B96C-4984-B510-1AE1F7401DF9

Q35609692-268D2D24-CE08-4F10-A1A5-B07F382495CC

Q35609692-27CE0517-96AF-4AA1-9AA6-9D2FCA6AFF70

Q35609692-2CBE43AD-7C21-41F7-BEBE-A720425DA14D

Q35609692-2E11F43C-6140-4722-8719-72D23DCBDD51

Q35609692-343F117F-4045-4CC5-81D0-398235329C55

P304

Q35609692-499DFE9D-B8FA-45C7-B69C-756D45634DD2

P31

Q35609692-DD9C6667-1403-4915-95A2-12B4B6A631F8

P356

Q35609692-5DBD3A8A-EFDC-48B0-B49E-C101C6358820

P407

Q35609692-8E2DBC4C-9532-4CCF-8B38-DD967CA9EF22

P433

Q35609692-E659CED2-9A45-4318-84E8-50308366F130

P478

Q35609692-3C5825EB-B739-44D1-9A38-D35A4679B16B

P50

Q35609692-25BAD30A-6AD1-43A6-B563-BC18CE3E6F72

Q35609692-6B70DF2F-4280-452D-AF57-58D2872C62DA

P577

Q35609692-674AA5DB-DAFF-4E91-9887-A41551860BEB

P698

Q35609692-3F0277FC-DB70-4156-8C88-0196513B57D4

P921

Q35609692-7FC45EF8-24B3-4B00-A526-3D97F33D1EBB

P932

Q35609692-AE451467-4417-4F07-A725-F31E9AA203AD

P356

JCO.2010.33.8020

P1433

Journal of Clinical Oncology

P1476

Nomogram for predicting the be ...... or resected gallbladder cancer

@en

P2093

Andrew Lemieux

http://www.w3.org/2001/XMLSchema#string

Celine B Ord

http://www.w3.org/2001/XMLSchema#string

Charles R Thomas

http://www.w3.org/2001/XMLSchema#string

Gary V Walker

http://www.w3.org/2001/XMLSchema#string

Jong-Sung Kim

http://www.w3.org/2001/XMLSchema#string

Samuel J Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer.

Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment

Rational therapeutic strategy for T2 gallbladder carcinoma based on tumor spread.

Population-based validation of the prognostic model ADJUVANT! for early breast cancer.

Parametric survival models for predicting the benefit of adjuvant chemoradiotherapy in gallbladder cancer.

Irradiation therapy for gallbladder carcinoma: recent advances.

Cancers of the gallbladder and biliary ducts.

Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer.

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.

P304

4627-4632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2010.33.8020

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Clifton D. Fuller

Jayashree Kalpathy-Cramer

P577

2011-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22067404

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

3236647

http://www.w3.org/2001/XMLSchema#string